Dermatitis Atopic clinical trials

Explore recruiting dermatitis atopic clinical trials.

Recruiting dermatitis atopic studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dermatitis Atopic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.

Belgium, Hungary

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A multinational, multicenter, double-blind, placebo-controlled phase 2 study to evaluate efficacy and safety of SAR444656 in adult participants with moderate to severe atopic dermatitis.

Germany, Poland, Greece, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants with Moderate to Severe Atopic Dermatitis.

Czechia, Poland, Germany, Italy, Bulgaria, France +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, DDI study to investigate the effects of amlitelimab on the PK of selected cytochrome P450 substrates

Germany, Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2b, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of 3 subcutaneous dose regimens of lunsekimig (SAR443765) in adult participants with moderate to-severe atopic dermatitis

Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

Netherlands, Denmark, Hungary, Ireland, Portugal, Italy +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dermatitis Atopic trials by city

Dermatitis Atopic in Toronto Dermatitis Atopic in Vancouver Dermatitis Atopic in Montreal Dermatitis Atopic in Calgary Dermatitis Atopic in Edmonton Dermatitis Atopic in Ottawa Dermatitis Atopic in Winnipeg Dermatitis Atopic in Quebec City Dermatitis Atopic in Hamilton Dermatitis Atopic in Kitchener Dermatitis Atopic in London Dermatitis Atopic in Halifax Dermatitis Atopic in New York Dermatitis Atopic in Los Angeles Dermatitis Atopic in Chicago Dermatitis Atopic in Houston

Dermatitis Atopic clinical trials

Recruiting dermatitis atopic studies right now

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants

Ethnic Differences in Mechanisms of Action of Dupilumab

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Also recruiting in Europe

A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.

A multinational, multicenter, double-blind, placebo-controlled phase 2 study to evaluate efficacy and safety of SAR444656 in adult participants with moderate to severe atopic dermatitis.

Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants with Moderate to Severe Atopic Dermatitis.

An open-label, DDI study to investigate the effects of amlitelimab on the PK of selected cytochrome P450 substrates

A Phase 2b, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of 3 subcutaneous dose regimens of lunsekimig (SAR443765) in adult participants with moderate to-severe atopic dermatitis

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

Dermatitis Atopic trials by city

Other conditions